Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHA:603139)

China flag China · Delayed Price · Currency is CNY
36.30
-0.48 (-1.31%)
Apr 30, 2026, 3:00 PM CST
88.38%
Market Cap 3.63B
Revenue (ttm) 513.23M
Net Income (ttm) -183.84M
Shares Out 99.88M
EPS (ttm) -1.86
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6,677,906
Average Volume 5,487,962
Open 36.59
Previous Close 36.78
Day's Range 35.64 - 37.20
52-Week Range 18.78 - 37.09
Beta 0.33
RSI 69.64
Earnings Date Apr 24, 2026

About SHA:603139

Shaanxi Kanghui Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. It offers gynecological, orthopedic, dermatology, diabetes, respiratory system, urinary system, cardiovascular, tranquilizer, gastrointestinal, hepatobiliary, and other drugs in the form of tablets, capsules, granules, mixtures, teas, plasters, ointments, liniments, lotions, and tinctures. The company was founded in 1999 and is based in Xianyang, China. [Read more]

Sector Healthcare
Founded 1999
Employees 906
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603139
Full Company Profile

Financial Performance

In 2024, SHA:603139's revenue was 561.63 million, a decrease of -16.54% compared to the previous year's 672.96 million. Losses were -89.63 million, 242.6% more than in 2023.

Financial Statements

News

There is no news available yet.